Skip to main content

EARNEST PARTNERS LLC

Position in NVS — Novartis AG

CIK 1102578 ATLANTA, GA

Position in NVS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$135,228,047
+$8,195,181 QoQ
Shares Held
885,290
-3.9% QoQ
Ownership
0.046%
of shares outstanding
% of Portfolio
0.56%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 80.04495701973364.ToString("F0")% Shared 0.009601373561205932.ToString("F0")% None 19.945441606705145.ToString("F0")%

Common Shares in NVS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Mar 31, 2026

EARNEST PARTNERS LLC holds $135,812,097 across 3 Drug Manufacturers - General names. NVS ranks #1 (99.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 NVS
Novartis AG
This page
885,290 $135,228,047

All Filings in NVS

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $135,228,047 885,290
2025-12-31 $127,032,866 921,396
2025-09-30 $107,724,934 840,026
2025-06-30 $102,883,549 850,207
2025-03-31 $91,900,879 824,371
2024-12-31 $77,450,099 795,911
2024-09-30 $93,068,087 809,147
2024-06-30 $86,156,694 809,287
2024-03-31 $80,822,848 835,551
2023-12-31 $82,191,195 814,016
2023-09-30 $83,101,258 815,838
2023-06-30 $84,765,207 840,008
2023-03-31 $78,270,104 850,762
2022-12-31 $77,754,025 857,077
2022-09-30 $66,259,285 871,718
2022-06-30 $73,281,931 866,934
2022-03-31 $78,406,906 893,526
2021-12-31 $79,144,430 904,818
2021-09-30 $77,054,097 942,212
2021-06-30 $90,806,518 995,249
2021-03-31 $91,667,127 1,072,381
2020-12-31 $93,742,832 992,723
2020-09-30 $84,530,511 972,062
2020-06-30 $86,517,257 990,580
2020-03-31 $109,891,091 1,332,821